DA Davidson Weighs in on Clorox’s FY2026 Earnings (NYSE:CLX)

The Clorox Company (NYSE:CLX) – Investment analysts at DA Davidson raised their FY2026 earnings estimates for shares of Clorox in a report released on Monday, November 4th. DA Davidson analyst L. Weiser now anticipates that the company will earn $6.61 per share for the year, up from their prior forecast of $6.31. DA Davidson has a “Neutral” rating and a $171.00 price target on the stock. The consensus estimate for Clorox’s current full-year earnings is $6.81 per share.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating the consensus estimate of $1.36 by $0.50. The firm had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company’s quarterly revenue was up 27.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.49 earnings per share.

Several other analysts have also recently weighed in on the company. Deutsche Bank Aktiengesellschaft lifted their price objective on Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Jefferies Financial Group raised Clorox from a “hold” rating to a “buy” rating and upped their price target for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Evercore ISI dropped their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday, October 14th. BNP Paribas raised Clorox to a “strong sell” rating in a research report on Friday, September 6th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research report on Friday, October 11th. Five equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $155.00.

Clorox Price Performance

Shares of CLX stock opened at $162.70 on Wednesday. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. Clorox has a fifty-two week low of $127.60 and a fifty-two week high of $169.09. The firm has a market cap of $20.14 billion, a P/E ratio of 56.69, a P/E/G ratio of 3.11 and a beta of 0.41. The business’s 50 day moving average price is $161.89 and its 200-day moving average price is $146.58.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be issued a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.00%. Clorox’s dividend payout ratio (DPR) is 170.03%.

Insiders Place Their Bets

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 0.57% of the company’s stock.

Hedge Funds Weigh In On Clorox

Large investors have recently made changes to their positions in the company. SG Americas Securities LLC raised its position in Clorox by 1,525.7% during the 1st quarter. SG Americas Securities LLC now owns 65,612 shares of the company’s stock valued at $10,046,000 after purchasing an additional 61,576 shares in the last quarter. Mizuho Markets Americas LLC raised its stake in shares of Clorox by 93.7% in the first quarter. Mizuho Markets Americas LLC now owns 72,053 shares of the company’s stock worth $11,032,000 after purchasing an additional 34,864 shares during the last quarter. CANADA LIFE ASSURANCE Co lifted its stake in Clorox by 15.2% during the 1st quarter. CANADA LIFE ASSURANCE Co now owns 141,622 shares of the company’s stock valued at $21,705,000 after acquiring an additional 18,687 shares during the period. Advisors Asset Management Inc. lifted its position in Clorox by 257.5% during the first quarter. Advisors Asset Management Inc. now owns 11,228 shares of the company’s stock valued at $1,719,000 after purchasing an additional 8,087 shares during the period. Finally, Raymond James & Associates boosted its stake in shares of Clorox by 32.8% in the second quarter. Raymond James & Associates now owns 267,632 shares of the company’s stock worth $36,524,000 after buying an additional 66,149 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.